1
|
Ady J, Thayanithy V, Mojica K, Wong P, Carson J, Rao P, Fong Y, Lou E. Tunneling nanotubes: an alternate route for propagation of the bystander effect following oncolytic viral infection. MOLECULAR THERAPY-ONCOLYTICS 2016; 3:16029. [PMID: 27933314 PMCID: PMC5142513 DOI: 10.1038/mto.2016.29] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/25/2016] [Revised: 09/21/2016] [Accepted: 09/22/2016] [Indexed: 12/31/2022]
Abstract
Tunneling nanotubes (TNTs) are ultrafine, filamentous actin-based cytoplasmic extensions which form spontaneously to connect cells at short and long-range distances. We have previously described long-range intercellular communication via TNTs connecting mesothelioma cells in vitro and demonstrated TNTs in intact tumors from patients with mesothelioma. Here, we investigate the ability of TNTs to mediate a viral thymidine kinase based bystander effect after oncolytic viral infection and administration of the nucleoside analog ganciclovir. Using confocal microscopy we assessed the ability of TNTs to propagate enhanced green fluorescent protein (eGFP), which is encoded by the herpes simplex virus NV1066, from infected to uninfected recipient cells. Using time-lapse imaging, we observed eGFP expressed in infected cells being transferred via TNTs to noninfected cells; additionally, increasing fluorescent activity in recipient cells indicated cell-to-cell transmission of the eGFP-expressing NV1066 virus had also occurred. TNTs mediated cell death as a form of direct cell-to-cell transfer following viral thymidine kinase mediated activation of ganciclovir, inducing a unique long-range form of the bystander effect through transmission of activated ganciclovir to nonvirus-infected cells. Thus, we provide proof-of-principle demonstration of a previously unknown and alternative mechanism for inducing apoptosis in noninfected recipient cells. The conceptual advance of this work is that TNTs can be harnessed for delivery of oncolytic viruses and of viral thymidine kinase activated drugs to amplify the bystander effect between cancer cells over long distances in stroma-rich tumor microenvironments.
Collapse
Affiliation(s)
- Justin Ady
- Department of Surgery, Memorial Sloan-Kettering Cancer Center , New York, New York, USA
| | - Venugopal Thayanithy
- Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota , Minneapolis, Minnesota, USA
| | - Kelly Mojica
- Department of Surgery, Memorial Sloan-Kettering Cancer Center , New York, New York, USA
| | - Phillip Wong
- Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota , Minneapolis, Minnesota, USA
| | - Joshua Carson
- Department of Surgery, Memorial Sloan-Kettering Cancer Center , New York, New York, USA
| | - Prassanna Rao
- Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota , Minneapolis, Minnesota, USA
| | - Yuman Fong
- Department of Surgery, Memorial Sloan-Kettering Cancer Center , New York, New York, USA
| | - Emil Lou
- Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota , Minneapolis, Minnesota, USA
| |
Collapse
|
2
|
Lou E, O'Hare P, Subramanian S, Steer CJ. Lost in translation: applying 2D intercellular communication via tunneling nanotubes in cell culture to physiologically relevant 3D microenvironments. FEBS J 2016; 284:699-707. [PMID: 27801976 DOI: 10.1111/febs.13946] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2016] [Revised: 10/17/2016] [Accepted: 10/28/2016] [Indexed: 01/09/2023]
Abstract
Tunneling nanotubes (TNTs) are membranous conduits for direct cell-to-cell communication. Until the past decade, little had been known about their composite structure, function, and mechanisms of action in both normal physiologic conditions as well as in disease states. Now TNTs are attracting increasing interest for their key role(s) in the pathogenesis of disease, including neurodegenerative disorders, inflammatory and infectious diseases, and cancer. The field of TNT biology is still in its infancy, but inroads have been made in determining potential mechanisms and function of these remarkable structures. For example, TNTs function as critical conduits for cellular exchange of information; thus, in cancer, they may play an important role in critical pathophysiologic features of the disease, including cellular invasion, metastasis, and emergence of chemotherapy drug resistance. Although the TNT field is still in a nascent stage, we propose that TNTs can be investigated as novel targets for drug-based treatment of cancer and other diseases.
Collapse
Affiliation(s)
- Emil Lou
- Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA
| | - Patrick O'Hare
- Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA
| | | | - Clifford J Steer
- Departments of Medicine and Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN, USA
| |
Collapse
|
3
|
Lou E, Fujisawa S, Barlas A, Romin Y, Manova-Todorova K, Moore MAS, Subramanian S. Tunneling Nanotubes: A new paradigm for studying intercellular communication and therapeutics in cancer. Commun Integr Biol 2012; 5:399-403. [PMID: 23060969 PMCID: PMC3460850 DOI: 10.4161/cib.20569] [Citation(s) in RCA: 87] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
Abstract
Tunneling nanotubes are actin-based cytoplasmic extensions that function as intercellular channels in a wide variety of cell types.There is a renewed and keen interest in the examination of modes of intercellular communication in cells of all types, especially in the field of cancer biology. Tunneling nanotubes –which in the literature have also been referred to as “membrane nanotubes,” “’intercellular’ or ‘epithelial’ bridges,” or “cytoplasmic extensions” – are under active investigation for their role in facilitating direct intercellular communication. These structures have not, until recently, been scrutinized as a unique and previously unrecognized form of direct cell-to-cell transmission of cellular cargo in the context of human cancer. Our recent study of tunneling nanotubes in human malignant pleural mesothelioma and lung adenocarcinomas demonstrated efficient transfer of cellular contents, including proteins, Golgi vesicles, and mitochondria, between cells derived from several well-established cancer cell lines. Further, we provided effective demonstration that such nanotubes can form between primary malignant cells from human patients. For the first time, we also demonstrated the in vivo relevance of these structures in humans, having effectively imaged nanotubes in intact solid tumors from patients. Here we provide further analysis and discussion on our findings, and offer a prospective ‘road map’ for studying tunneling nanotubes in the context of human cancer. We hope that further understanding of the mechanisms, methods of transfer, and particularly the role of nanotubes in tumor-stromal cross-talk will lead to identification of new selective targets for cancer therapeutics.
Collapse
Affiliation(s)
- Emil Lou
- Division of Hematology; Oncology and Transplantation; University of Minnesota; Minneapolis, MN USA
| | | | | | | | | | | | | |
Collapse
|
4
|
Lou E, Fujisawa S, Morozov A, Barlas A, Romin Y, Dogan Y, Gholami S, Moreira AL, Manova-Todorova K, Moore MAS. Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesothelioma. PLoS One 2012; 7:e33093. [PMID: 22427958 PMCID: PMC3302868 DOI: 10.1371/journal.pone.0033093] [Citation(s) in RCA: 309] [Impact Index Per Article: 23.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2011] [Accepted: 02/09/2012] [Indexed: 12/20/2022] Open
Abstract
Tunneling nanotubes are long, non-adherent F-actin-based cytoplasmic extensions which connect proximal or distant cells and facilitate intercellular transfer. The identification of nanotubes has been limited to cell lines, and their role in cancer remains unclear. We detected tunneling nanotubes in mesothelioma cell lines and primary human mesothelioma cells. Using a low serum, hyperglycemic, acidic growth medium, we stimulated nanotube formation and bidirectional transfer of vesicles, proteins, and mitochondria between cells. Notably, nanotubes developed between malignant cells or between normal mesothelial cells, but not between malignant and normal cells. Immunofluorescent staining revealed their actin-based assembly and structure. Metformin and an mTor inhibitor, Everolimus, effectively suppressed nanotube formation. Confocal microscopy with 3-dimensional reconstructions of sectioned surgical specimens demonstrated for the first time the presence of nanotubes in human mesothelioma and lung adenocarcinoma tumor specimens. We provide the first evidence of tunneling nanotubes in human primary tumors and cancer cells and propose that these structures play an important role in cancer cell pathogenesis and invasion.
Collapse
Affiliation(s)
- Emil Lou
- Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
- Moore Laboratory, Department of Cell Biology, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
| | - Sho Fujisawa
- Molecular Cytology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
| | - Alexei Morozov
- Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
- Moore Laboratory, Department of Cell Biology, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
| | - Afsar Barlas
- Molecular Cytology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
| | - Yevgeniy Romin
- Molecular Cytology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
| | - Yildirim Dogan
- Moore Laboratory, Department of Cell Biology, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
| | - Sepideh Gholami
- Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
| | - André L. Moreira
- Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
| | - Katia Manova-Todorova
- Molecular Cytology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
| | - Malcolm A. S. Moore
- Moore Laboratory, Department of Cell Biology, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America
| |
Collapse
|